Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever
HematologiaSobre o estudo
- Desenho
- Ensaio clínico randomizado
- Nível de evidência
- 2 · Nova evidência
- Revista
- Mycoses
- Publicado em
- 28 mai 2020
- Citações
- 0
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Intravenous itraconazole compared with liposomal amphotericin B as empirical antifungal therapy in patients with neutropaenia and persistent fever
Isao Yoshida, Akiko M Saito, Shiro Tanaka, Ilseung Choi, Michihiro Hidaka, Yasuhiko Miyata, Yoshiko Inoue, Satoshi Yamasaki, Toshiya Kagoo, Hiroatsu Iida et al.
Descritores MeSH
- Amphotericin B
- Mycoses
- Itraconazole
- Chemotherapy-Induced Febrile Neutropenia
- Humans
- Male
- Adult
- Hematologic Neoplasms
- Young Adult
- Administration, Intravenous
Veja também
Estudos relacionados
- D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial
- Endoscopic and intrathecal management of intraventricular fungal infections: a case report of Cladophialophora bantiana and systematic review
- Primary antifungal prophylaxis in hematological malignancies. Updated clinical practice guidelines by the European Conference on Infections in Leukemia (ECIL)
- Safety and Effectiveness of High-dose Liposomal Amphotericin B: A Systematic Review and Meta-analysis